NaaS Technology Inc. to Participate in Upcoming Investor Conferences in February 2025
BEIJING,Feb. 12,2025-- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"),the first U.S.-listed EV charging service company in China,today announced that management will
TOKYO,Feb. 12,2025-- NIPPON EXPRESS HOLDINGS,INC.,released "\'RISE\' Global Semiconductor with NX Logistics," a video introducing the NX Group\'s logistics solutions for the semiconductor in
BANGKOK,Feb. 12,2025-- On January 9,2025,Wanda Jin Residences The Ease Sierra Bangkok,situated in the heart of Thailand\'s capital,celebrated its grand opening. As Wanda Hotels & Resorts\' maiden
HD Korea Shipbuilding & Offshore Engineering Leads the Zero-Carbon Era with 'SMR-Powered Ship'
- Received Approval in Principle (AIP) from the American Bureau of Shipping (ABS) for nuclear-powered container ship
Manulife Asia Announces Senior Leadership Team Changes
Changes Include Emerging Markets,Indonesia,Japan,Singapore and Finance HONG KONG,February10,2025-- Manulife Asia has announced strategic changes to its senior leadership team across Emerging Markets,
ChipMOS REPORTS JANUARY 2025 REVENUE
HSINCHU,Feb. 10,2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS),an industry leading provider of
Address Advisors Setting Benchmarks for GCC's Real Estate Solutions in India
SINGAPORE and BENGALURU,India,Feb. 10,2025-- Address Advisors,a leading real estate consulting firm in India,is offering the GCCs entering the Indian market comprehensive support. Through their occup
Global Leader in Robotic Pool Cleaning Pushes the Boundaries of Performance and Technology with New Collaboration and Product Offerings
Unveiled at the French AI Action Summit,ROOST equips builders with scalable solutionsto promote AI safety and help protect young people in the digital age
SUZHOU,China,Feb. 10,2025-- CStone Pharmaceuticals ("CStone",HKEX: 2616),an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies,today